SG43787A1 - Novel paroxetine hydrochloride anhydrate - Google Patents

Novel paroxetine hydrochloride anhydrate

Info

Publication number: SG43787A1
Authority: SG; Singapore
Prior art keywords: paroxetine hydrochloride; hydrochloride anhydrate; novel; novel paroxetine; anhydrate
Prior art date: 1995-02-06

Application number

SG1996000861A

Other languages

English (en)

Inventor

Victor Witold Jacewicz

Neal Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-06

Filing date

1996-02-03

Publication date

1997-11-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG43787(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-02-06 Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en

1995-02-17 Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en

1995-05-15 Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en

1996-02-03 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1997-11-14 Publication of SG43787A1 publication Critical patent/SG43787A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SG1996000861A 1995-02-06 1996-02-03 Novel paroxetine hydrochloride anhydrate SG43787A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9502297.6A GB9502297D0 (en)	1995-02-06	1995-02-06	Novel compound
GBGB9503112.6A GB9503112D0 (en)	1995-02-17	1995-02-17	Novel compound
GBGB9509807.5A GB9509807D0 (en)	1995-05-15	1995-05-15	Novel compounds

Publications (1)

Publication Number	Publication Date
SG43787A1 true SG43787A1 (en)	1997-11-14

Family

ID=27267578

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996000861A SG43787A1 (en)	1995-02-06	1996-02-03	Novel paroxetine hydrochloride anhydrate

Country Status (47)

Country	Link
EP (3)	EP1136490B1 (fr)
JP (2)	JP2915338B2 (fr)
KR (1)	KR100289885B1 (fr)
CN (3)	CN1090187C (fr)
AR (2)	AR001982A1 (fr)
AT (1)	AT407528B (fr)
AU (2)	AU4786496A (fr)
BE (1)	BE1009112A3 (fr)
BG (1)	BG62967B1 (fr)
BR (1)	BR9600534A (fr)
CA (4)	CA2168829C (fr)
CH (3)	CH689804A5 (fr)
CZ (1)	CZ297171B6 (fr)
DE (3)	DE69631298T2 (fr)
DK (2)	DK11996A (fr)
DZ (1)	DZ1989A1 (fr)
ES (1)	ES2114471B1 (fr)
FI (3)	FI111544B (fr)
FR (1)	FR2730232B1 (fr)
GR (1)	GR1002466B (fr)
HK (1)	HK59397A (fr)
HU (1)	HUP9600255A1 (fr)
IE (1)	IE80500B1 (fr)
IL (1)	IL117035A (fr)
IT (1)	IT1289532B1 (fr)
LU (1)	LU88711A1 (fr)
LV (1)	LV11618B (fr)
MA (1)	MA23802A1 (fr)
MC (1)	MC2411A1 (fr)
MX (1)	MX9600484A (fr)
MY (1)	MY132529A (fr)
NL (1)	NL1002248C2 (fr)
NO (3)	NO301009B1 (fr)
NZ (1)	NZ280943A (fr)
OA (1)	OA10261A (fr)
PL (1)	PL189247B1 (fr)
PT (1)	PT101827B (fr)
RO (1)	RO112426B1 (fr)
RU (1)	RU2125052C1 (fr)
SE (1)	SE521084C2 (fr)
SG (1)	SG43787A1 (fr)
SI (2)	SI21923B (fr)
SK (1)	SK283608B6 (fr)
TR (1)	TR199600096A2 (fr)
TW (1)	TW503238B (fr)
UA (1)	UA49796C2 (fr)
WO (1)	WO1996024595A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3882224B2 (ja)	1996-05-31	2007-02-14	旭硝子株式会社	パロキセチンの製造方法
EP1384720A1 (fr) *	1996-06-13	2004-01-28	SUMIKA FINE CHEMICALS Co., Ltd.	Procédé de séchage pour le chlorhydrate de paroxetine
JP2000514653A (ja) *	1996-07-15	2000-11-07	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	立体特異的分割のためのエステラーゼのスクリーニングおよびその使用
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US5672612A (en) *	1996-09-09	1997-09-30	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
CA2193939C (fr) *	1996-12-24	2002-02-12	K.S. Keshava Murthy	Forme utile de chlorhydrate de paroxetine anhydre
ES2155995T3 (es) *	1997-06-10	2001-06-01	Synthon Bv	Compuestos de 4-fenilpiperidina.
PT903345E (pt) *	1997-08-08	2001-01-31	Aventis Pharma Gmbh	Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida
GB9726907D0 (en) *	1997-12-19	1998-02-18	Smithkline Beecham Plc	Novel compounds
EA200000946A1 (ru) *	1998-03-16	2001-02-26	Смитклайн Бичам Плс	Кристаллическая форма пароксетина
US6699882B2 (en)	1998-03-24	2004-03-02	Smithkline Beecham P.L.C.	Paroxetine compositions
GB9806312D0 (en) *	1998-03-24	1998-05-20	Smithkline Beecham Plc	Novel formulations
AU2003200534B2 (en) *	1998-03-24	2004-12-02	Smithkline Beecham Plc	Paroxetine compositions
JP3796351B2 (ja)	1998-04-13	2006-07-12	住友化学株式会社	パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) *	1998-06-16	1998-08-12	Smithkline Beecham Plc	Method of treatment
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es)	1998-07-07	2000-10-01	Medichem Sa	Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
PL345885A1 (en) *	1998-08-07	2002-01-14	Smithkline Beecham Plc	Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) *	1998-11-05	1998-12-30	Smithkline Beecham Plc	Novel process
GB9826176D0 (en) *	1998-11-28	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826175D0 (en) *	1998-11-28	1999-01-20	Smithkline Beecham Plc	Novel process
ES2211232T3 (es) *	1998-11-30	2004-07-01	Smithkline Beecham Plc	Solvatos mixtos de paroxetina-propan-2-ol.
GB9826178D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826180D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826242D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826171D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel compounds
GB9828767D0 (en) *	1998-12-29	1999-02-17	Smithkline Beecham Plc	Novel process
IT1308629B1 (it) *	1999-02-23	2002-01-09	Recordati Chem Pharm	Processo per la produzione di paroxetina.
ATE311883T1 (de) *	1999-03-12	2005-12-15	Aesica Pharmaceuticals Ltd	Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914583D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
GB9914585D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
SE9902550D0 (sv) *	1999-07-02	1999-07-02	Astra Ab	New crystalline forms
GB9919001D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel process
GB9923446D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
GB9923439D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
GB9923445D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
HU226912B1 (en) *	2000-04-07	2010-03-01	Richter Gedeon Nyrt	New paroxetin salt and medicament containing it
WO2002022609A1 (fr) *	2000-09-14	2002-03-21	Asahi Glass Company, Limited	Procede de production de sel de paroxetine sensiblement exempt de solvant organique
CA2476723A1 (fr) *	2002-02-22	2003-09-04	Gideon Pilarski	Preparation de paroxetine impliquant de nouveaux intermediaires
US7563930B2 (en) *	2005-11-22	2009-07-21	Teva Pharmaceutical Industries Ltd	Crystal forms of Cinacalcet HCI and processes for their preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
DE3688827T2 (de) *	1985-10-25	1994-03-31	Beecham Group Plc	Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
US5017585A (en) *	1986-11-03	1991-05-21	Novo Nordisk A/S	Method of treating calcium overload
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
DK715988D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Reduktion af piperidin-dion-derivater samt intermediat
CA2096853A1 (fr) *	1990-11-24	1992-05-25	Anthony Michael Johnson	Emploi de la paroxetine pour le traitement de la demence senile, de la boulimie, de la migraine ou de l'anorexie
US5258517A (en) *	1992-08-06	1993-11-02	Sepracor, Inc.	Method of preparing optically pure precursors of paroxetine
GB9325644D0 (en) *	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation

1996
- 1996-02-01 SK SK143-96A patent/SK283608B6/sk not_active IP Right Cessation
- 1996-02-01 AR ARP960101230A patent/AR001982A1/es not_active Application Discontinuation
- 1996-02-02 EP EP01115079A patent/EP1136490B1/fr not_active Expired - Lifetime
- 1996-02-02 DE DE1996631298 patent/DE69631298T2/de not_active Expired - Lifetime
- 1996-02-02 DE DE19603797A patent/DE19603797C2/de not_active Revoked
- 1996-02-02 IE IE960104A patent/IE80500B1/en not_active IP Right Cessation
- 1996-02-02 AU AU47864/96A patent/AU4786496A/en not_active Abandoned
- 1996-02-02 EP EP96903970A patent/EP0808314B1/fr not_active Expired - Lifetime
- 1996-02-02 MX MX9600484A patent/MX9600484A/es not_active IP Right Cessation
- 1996-02-02 FR FR9601297A patent/FR2730232B1/fr not_active Expired - Fee Related
- 1996-02-02 CZ CZ0032096A patent/CZ297171B6/cs not_active IP Right Cessation
- 1996-02-02 MY MYPI96000383A patent/MY132529A/en unknown
- 1996-02-02 DE DE69621777T patent/DE69621777T2/de not_active Expired - Lifetime
- 1996-02-02 BR BR9600534A patent/BR9600534A/pt not_active IP Right Cessation
- 1996-02-02 RO RO96-00183A patent/RO112426B1/ro unknown
- 1996-02-02 AU AU43328/96A patent/AU701518C/en not_active Ceased
- 1996-02-02 MC MC2329A patent/MC2411A1/fr unknown
- 1996-02-02 EP EP03078024A patent/EP1378508A1/fr not_active Withdrawn
- 1996-02-02 LV LVP-96-31A patent/LV11618B/en unknown
- 1996-02-02 WO PCT/EP1996/000447 patent/WO1996024595A1/fr not_active Ceased
- 1996-02-03 SG SG1996000861A patent/SG43787A1/en unknown
- 1996-02-03 KR KR1019960002620A patent/KR100289885B1/ko not_active Expired - Fee Related
- 1996-02-04 DZ DZ960030A patent/DZ1989A1/fr active
- 1996-02-05 TW TW085101374A patent/TW503238B/zh not_active IP Right Cessation
- 1996-02-05 CN CN96103526A patent/CN1090187C/zh not_active Expired - Fee Related
- 1996-02-05 SI SI9600378A patent/SI21923B/sl not_active IP Right Cessation
- 1996-02-05 ES ES09600262A patent/ES2114471B1/es not_active Expired - Fee Related
- 1996-02-05 NL NL1002248A patent/NL1002248C2/xx not_active IP Right Cessation
- 1996-02-05 SE SE9600406A patent/SE521084C2/sv not_active IP Right Cessation
- 1996-02-05 IL IL11703596A patent/IL117035A/xx unknown
- 1996-02-05 PL PL96312646A patent/PL189247B1/pl unknown
- 1996-02-05 HU HU9600255A patent/HUP9600255A1/hu unknown
- 1996-02-05 BG BG100333A patent/BG62967B1/bg unknown
- 1996-02-05 CA CA002168829A patent/CA2168829C/fr not_active Expired - Fee Related
- 1996-02-05 DK DK011996A patent/DK11996A/da not_active Application Discontinuation
- 1996-02-05 AT AT0021096A patent/AT407528B/de not_active IP Right Cessation
- 1996-02-05 UA UA96020442A patent/UA49796C2/uk unknown
- 1996-02-05 FI FI960519A patent/FI111544B/fi not_active IP Right Cessation
- 1996-02-05 NZ NZ280943A patent/NZ280943A/en not_active IP Right Cessation
- 1996-02-05 JP JP8018679A patent/JP2915338B2/ja not_active Expired - Fee Related
- 1996-02-05 CA CA002210023A patent/CA2210023C/fr not_active Expired - Fee Related
- 1996-02-05 SI SI9600036A patent/SI9600036B/sl not_active IP Right Cessation
- 1996-02-05 MA MA24157A patent/MA23802A1/fr unknown
- 1996-02-05 GR GR960100038A patent/GR1002466B/el not_active IP Right Cessation
- 1996-02-05 CA CA002211522A patent/CA2211522C/fr not_active Expired - Fee Related
- 1996-02-05 LU LU88711A patent/LU88711A1/fr unknown
- 1996-02-05 RU RU96102180A patent/RU2125052C1/ru not_active IP Right Cessation
- 1996-02-05 CN CNB2004100855519A patent/CN1289496C/zh not_active Expired - Fee Related
- 1996-02-05 CA CA002210022A patent/CA2210022C/fr not_active Expired - Fee Related
- 1996-02-05 BE BE9600101A patent/BE1009112A3/fr not_active IP Right Cessation
- 1996-02-05 NO NO960472A patent/NO301009B1/no not_active IP Right Cessation
- 1996-02-05 IT IT96MI000203A patent/IT1289532B1/it active IP Right Grant
- 1996-02-06 OA OA60773A patent/OA10261A/en unknown
- 1996-02-06 CH CH02051/98A patent/CH689804A5/de not_active IP Right Cessation
- 1996-02-06 PT PT101827A patent/PT101827B/pt not_active IP Right Cessation
- 1996-02-06 TR TR96/00096A patent/TR199600096A2/xx unknown
- 1996-02-06 CH CH00304/96A patent/CH688353A5/de not_active IP Right Cessation
- 1996-02-06 CH CH01510/97A patent/CH689229A5/de not_active IP Right Cessation
1997
- 1997-02-28 NO NO19970939A patent/NO311519B1/no not_active IP Right Cessation
- 1997-05-08 HK HK59397A patent/HK59397A/xx not_active IP Right Cessation
1998
- 1998-12-02 JP JP10342812A patent/JPH11228571A/ja active Pending
2000
- 2000-08-31 CN CN001268872A patent/CN1216055C/zh not_active Expired - Fee Related
2001
- 2001-02-12 DK DKPA200100223 patent/DK200100223A/da not_active Application Discontinuation
- 2001-10-18 NO NO20015070A patent/NO20015070D0/no not_active Application Discontinuation
2002
- 2002-10-18 AR ARP020103931A patent/AR036856A2/es unknown
2003
- 2003-02-03 FI FI20030162A patent/FI20030162A7/fi unknown
- 2003-03-12 FI FI20030370A patent/FI20030370A7/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
AT407528B (de)	2001-04-25
CH688353A5 (de)	1997-08-15
CA2210023A1 (fr)	1996-08-07
HU9600255D0 (en)	1996-03-28
IL117035A (en)	2000-02-29
EP0808314A1 (fr)	1997-11-26
IL117035A0 (en)	1996-09-12
DE19603797A1 (de)	1996-08-14
CN1636993A (zh)	2005-07-13
JPH11228571A (ja)	1999-08-24
WO1996024595A1 (fr)	1996-08-15
MC2411A1 (fr)	1996-12-02
MX9600484A (es)	1997-01-31
RU2125052C1 (ru)	1999-01-20
ITMI960203A0 (fr)	1996-02-05
NO970939D0 (no)	1997-02-28
NO311519B1 (no)	2001-12-03
CN1090187C (zh)	2002-09-04
TW503238B (en)	2002-09-21
NO301009B3 (fr)	2003-01-06
CN1143643A (zh)	1997-02-26
FI111544B (fi)	2003-08-15
SE521084C2 (sv)	2003-09-30
UA49796C2 (uk)	2002-10-15
JPH08245620A (ja)	1996-09-24
OA10261A (en)	1997-09-19
KR960031409A (ko)	1996-09-17
PT101827B (pt)	1997-08-29
NO20015070D0 (no)	2001-10-18
GR1002466B (el)	1996-11-06
CA2168829A1 (fr)	1996-08-07
EP1136490A1 (fr)	2001-09-26
HUP9600255A1 (en)	1997-03-28
ATA21096A (de)	2000-08-15
FI20030162L (fi)	2003-02-03
CA2211522A1 (fr)	1996-08-07
LV11618B (en)	1997-04-20
BR9600534A (pt)	1997-05-13
NO301009B1 (no)	1997-09-01
NO970939L (no)	1996-08-07
AU701518C (en)	2006-12-07
MA23802A1 (fr)	1996-10-01
CH689804A5 (de)	1999-11-30
RO112426B1 (ro)	1997-09-30
FI20030162A7 (fi)	2003-02-03
SK283608B6 (sk)	2003-10-07
AR036856A2 (es)	2004-10-06
ES2114471A1 (es)	1998-05-16
SI9600036A (en)	1996-10-31
AR001982A1 (es)	1998-01-07
IT1289532B1 (it)	1998-10-15
NL1002248A1 (nl)	1996-08-06
SI21923B (sl)	2006-12-31
BG100333A (bg)	1996-08-30
IE80500B1 (en)	1998-08-12
AU4786496A (en)	1996-08-27
FI960519L (fi)	1996-08-07
FI20030370L (fi)	2003-03-12
PL189247B1 (pl)	2005-07-29
SE9600406L (sv)	1996-08-07
DE69631298D1 (de)	2004-02-12
FI20030370A7 (fi)	2003-03-12
NL1002248C2 (nl)	1996-09-11
DE69631298T2 (de)	2004-11-18
FR2730232A1 (fr)	1996-08-09
AU701518B2 (en)	1999-01-28
LU88711A1 (fr)	1996-08-23
CA2168829C (fr)	1997-12-16
CA2210022A1 (fr)	1996-08-07
MY132529A (en)	2007-10-31
SI21923A (sl)	2006-06-30
CZ297171B6 (cs)	2006-09-13
EP1378508A1 (fr)	2004-01-07
LV11618A (lv)	1996-12-20
NO960472D0 (no)	1996-02-05
CH689229A5 (de)	1998-12-31
JP2915338B2 (ja)	1999-07-05
KR100289885B1 (ko)	2001-05-15
TR199600096A2 (tr)	1996-08-21
BE1009112A3 (fr)	1996-11-05
IE960104A1 (en)	1996-08-07
CN1289496C (zh)	2006-12-13
EP1136490B1 (fr)	2004-01-07
DE19603797C2 (de)	1998-11-12
NO960472L (no)	1996-08-07
CN1216055C (zh)	2005-08-24
BG62967B1 (bg)	2000-12-29
CZ32096A3 (en)	1996-08-14
CA2210022C (fr)	2005-09-13
FI960519A0 (fi)	1996-02-05
DE69621777D1 (de)	2002-07-18
NO20015070L (no)	1996-08-07
AU4332896A (en)	1996-08-15
FR2730232B1 (fr)	1997-08-01
CN1310180A (zh)	2001-08-29
HK59397A (en)	1997-05-16
SE9600406D0 (sv)	1996-02-05
CA2211522C (fr)	1999-12-07
SI9600036B (sl)	2006-12-31
PT101827A (pt)	1996-09-30
EP0808314B1 (fr)	2002-06-12
SK14396A3 (en)	1996-11-06
PL312646A1 (en)	1996-08-19
ITMI960203A1 (it)	1997-08-05
DK200100223A (fr)	2001-02-12
ES2114471B1 (es)	1999-08-16
NZ280943A (en)	1997-01-29
DE69621777T2 (de)	2003-01-02
CA2210023C (fr)	1999-02-09
MX198371B (fr)	2000-08-29
DK11996A (da)	1996-08-07
DZ1989A1 (fr)	2002-10-15

Publication	Publication Date	Title
SG43787A1 (en)	1997-11-14	Novel paroxetine hydrochloride anhydrate
GB2293382B (en)	1998-08-19	Crystalline raloxifene hydrochloride
DE69631390D1 (de)	2004-02-26	Substituierte Benzylaminpiperidin-Verbindungen
ZA962200B (en)	1996-10-30	Piperidine derivatives
EG24195A (en)	2008-10-14	Heterocyclic compounds
HU9500897D0 (en)	1995-05-29	Amine modified epoxide-resin
IL113472A0 (en)	1995-07-31	Non-peptidyl tachykinin receptor antogonists
ZA969753B (en)	1997-03-25	Crystalline hydrochloride of (r)-(-)-2-än-4-(1,1-dioxido-3-oxo-2,3-dihydrobenzhisothiazol-2-yl)-aminomethylü-chroman
IL129122A0 (en)	2000-02-17	N-substituted azaheterocyclic compounds
ZA9811345B (en)	1999-06-11	Piperidine derivatives
HU9701194D0 (en)	1997-09-29	4-hydroxy-piperidine derivatives
HU9601176D0 (en)	1996-06-28	Adhesion-receptor antagonists
PL322722A1 (en)	1998-02-16	Novel heterocyclic compounds
PL316382A1 (en)	1997-01-06	Novel derivatives of piperidine
DE69629454D1 (en)	2003-09-18	Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate
IL129121A0 (en)	2000-02-17	N-substituted azaheterocyclic compounds
GB2297550C2 (en)	1997-04-09	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
HRP970653B1 (en)	2001-12-31	4-hydroxy-piperidine derivatives
ZA955438B (en)	1996-02-13	Polyalkylpiperidine compounds
PL325637A1 (en)	1998-08-03	Novel heterocyclic compounds
HUP0004503A3 (en)	2002-04-29	Process for the preparation of paroxetine hydrochloride
AU740561C (en)	2005-12-08	Paroxetine hydrochloride anhydrate
EP0832124A4 (fr)	1999-12-22	Recepteur d'amines humaines
LT96007A (en)	1996-10-25	Paroxetine hydrochloride anhydrate and process for preparing thereof
GB9425502D0 (en)	1995-02-15	Novel receptor